The Indian Pharmaceuticals Market continued to deliver healthy growth at 8.7% year-on-year in January 2025, against 7.7% year ...

Natco Pharma said that it has received final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), which is a generic version of Tracleer by Actelion Pharmaceuticals US Inc.